# Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema

*PRI Rank #8 · Topics and Trends in Most Cited Retinal Development and Disorders Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/retinal-development-and-disorders/2026/rank-8*

| Field | Value |
| --- | --- |
| Rank | #8 |
| 18m citations | 36 |
| Journal | Eye |
| Year | 2024 |
| DOI | 10.1038/s41433-024-03364-y |
| Corresponding authors | Samantha R. De Silva |
| Institution | University of Oxford, United Kingdom |

**Ranking page:** [Topics and Trends in Most Cited Retinal Development and Disorders Papers, Class of 2026](https://pri.pepkio.com/top-papers/retinal-development-and-disorders/2026)

**Paper link:** [10.1038/s41433-024-03364-y](https://doi.org/10.1038/s41433-024-03364-y)

## Topics

faricimab · Anti-VEGF therapy · neovascular AMD · diabetic macular edema · partial response · treatment switching · Visual acuity · ETDRS letters · central subfield thickness · treatment interval extension · treatment resistance · anatomical response · Real-world outcomes · Oxford Eye Hospital · retrospective study

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Retinal Development and Disorders Papers, Class of 2026. https://pri.pepkio.com/top-papers/retinal-development-and-disorders/2026. Accessed 2026-10-28.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```